HeartSciences Shares Outstanding History (HSCS)
HeartSciences reported 3.2M shares outstanding at the end of fiscal 2026.
View full HeartSciences company overviewHeartSciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | 3.2M | 3.2M | +2848939.46% |
| 2025 | 2025-04-30 | 111.911 | 44.251 | +65.40% |
| 2024 | 2024-04-30 | 67.66 | 67.66 | +66770417931.82% |
| 2023 | 2023-04-30 | 0 | 0 | +204.85% |
| 2022 | 2022-04-30 | 0 | — | — |
HeartSciences quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | 3.2M | 3.2M | +28390.39% |
| Q3 2026 | 2026-01-31 | 3.2M | 3.2M | +308451147.24% |
| Q2 2026 | 2025-10-31 | 3.1M | 3.1M | +32402056828.47% |
| Q1 2026 | 2025-07-31 | 22,810.54 | 22,810.54 | +25165641283.21% |
| Q4 2025 | 2025-04-30 | 11,191.07 | 11,191.07 | +16540205457.81% |
| Q3 2025 | 2025-01-31 | 1.032 | 1.032 | +162284846.95% |
| Q2 2025 | 2024-10-31 | 0.009 | 0.009 | +8452445.95% |
| Q1 2025 | 2024-07-31 | 0 | 0 | +84842.15% |
| Q4 2024 | 2024-04-30 | 0 | 0 | +66767.82% |
| Q3 2024 | 2024-01-31 | 0 | 0 | +661.83% |
| Q2 2024 | 2023-10-31 | 0 | 0 | +36.57% |
| Q1 2024 | 2023-07-31 | 0 | 0 | +30.54% |
| Q4 2023 | 2023-04-30 | 0 | 0 | +204.41% |
| Q3 2023 | 2023-01-31 | 0 | — | — |
| Q2 2023 | 2022-10-31 | 0 | — | — |
| Q1 2023 | 2022-07-31 | 0 | — | — |
| Q4 2022 | 2022-04-30 | 0 | — | — |
HeartSciences shares outstanding trends
Across the available reported history, HeartSciences's shares outstanding moved from 111.911 to 3.2M, a change of 3.2M. The latest reported quarter, Q4 2026, shows 3.2M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences filings at SEC.gov ↗